Ignite Creation Date:
2024-05-06 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03655678
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-13
First Post:
2018-08-29
Brief Title:
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-29
First Submit QC Date:
August 30 2018
Study First Post Date:
2018-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-05-13
Last Update Post Date Type:
ACTUAL